{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:57:33Z","timestamp":1793048253729,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008043","name":"Zhejiang Sci-Tech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LKLY25H160002"],"award-info":[{"award-number":["LKLY25H160002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189652","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:28:25Z","timestamp":1782862105000},"page":"189652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Organoid-based platforms for oncolytic virus discovery and optimization: Bridging in vitro innovation and clinical translation"],"prefix":"10.1016","volume":"1881","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5007","key":"10.1016\/j.bbcan.2026.189652_bb0005","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.1851332","article-title":"Experimental therapy of human glioma by means of a genetically engineered virus mutant","volume":"252","author":"Martuza","year":"1991","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189652_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2018.08.042","article-title":"The advent of oncolytic virotherapy in oncology: the Rigvir\u00ae story","volume":"837","author":"Alberts","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189652_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1568009618666171129221503","article-title":"Oncorine, the world first oncolytic virus medicine and its update in China","volume":"18","author":"Liang","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbcan.2026.189652_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1719438","article-title":"Case report: local and systemic combination therapy: endoscopic injection of an oncolytic virus with PD-1 inhibitor for an elderly patient with advanced gastrointestinal cancer","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"issue":"30","key":"10.1016\/j.bbcan.2026.189652_bb0030","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/1759-7714.15101","article-title":"Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: a multicenter, observational, real-world study","volume":"14","author":"Wang","year":"2023","journal-title":"Thoracic Cancer"},{"key":"10.1016\/j.bbcan.2026.189652_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1592995","article-title":"Recombinant human adenovirus type 5 administration for the treatment of malignant ascites or pleural effusion in cancer patients: a meta-analysis","volume":"15","author":"Duan","year":"2025","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189652_bb0040","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.ymthe.2024.04.029","article-title":"Oncolytic adenovirus in treating malignant ascites: a phase II trial and longitudinal single-cell study","volume":"32","author":"Zhang","year":"2024","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.bbcan.2026.189652_bb0045","article-title":"Recombinant human type-5 adenovirus (H101) combined with radiofrequency ablation versus traditional radiofrequency ablation for hepatocellular carcinoma \u2264 3 cm: a phase III randomized controlled trial","author":"Dai","year":"2025","journal-title":"Int. J. Surg. (London, England)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031098","article-title":"Talimogene Laherparepvec (T-VEC): a review of the recent advances in cancer therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189652_bb0055","first-page":"667","article-title":"Teserpaturev\/G47\u0394: first approval","volume":"36","author":"Frampton","year":"2022","journal-title":"BioDrugs Clin. Immunotherap. Biopharm. Gene Ther."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189652_bb0060","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189652_bb0065","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.32604\/or.2025.061857","article-title":"Oncolytic virus therapy in hepatocellular carcinoma","volume":"33","author":"Ye","year":"2025","journal-title":"Oncol. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189652_bb0070","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1158\/0008-5472.CAN-12-2687","article-title":"Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans","volume":"73","author":"Breitbach","year":"2013","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189652_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","article-title":"Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals","volume":"3","author":"Eiraku","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"7244","key":"10.1016\/j.bbcan.2026.189652_bb0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189652_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease modeling in stem cell-derived 3D organoid systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189652_bb0090","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.stem.2021.03.012","article-title":"Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer","volume":"28","author":"L\u00f5hmussaar","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0095","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.stem.2024.01.012","article-title":"A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment","volume":"31","author":"Kastenschmidt","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2026.189652_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123546","article-title":"Generation of patient-derived sarcoma organoids for personalized drug screening and precision cancer immunotherapy","volume":"324","author":"Ma","year":"2026","journal-title":"Biomaterials"},{"issue":"6444","key":"10.1016\/j.bbcan.2026.189652_bb0110","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science (New York, N.Y.)"},{"issue":"15","key":"10.1016\/j.bbcan.2026.189652_bb0115","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101654","article-title":"Xenograft and organoid model systems in cancer research","volume":"38","author":"Bleijs","year":"2019","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189652_bb0120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc.2016.140","article-title":"Interrogating open issues in cancer precision medicine with patient-derived xenografts","volume":"17","author":"Byrne","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189652_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/OV.S165479","article-title":"Three-dimensional tumor cell cultures employed in virotherapy research","volume":"7","author":"Kloker","year":"2018","journal-title":"Oncolytic Virother."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189652_bb0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189652_bb0135","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1021\/acs.jmedchem.6b00770","article-title":"Functional characterization of cholera toxin inhibitors using human intestinal organoids","volume":"59","author":"Zomer-van Ommen","year":"2016","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189652_bb0140","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.stem.2023.05.012","article-title":"Organoid cultures for cancer modeling","volume":"30","author":"Yan","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2026.189652_bb0145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.omto.2022.01.009","article-title":"Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer","volume":"24","author":"Rangsitratkul","year":"2022","journal-title":"Mol. Ther. Oncolyt."},{"key":"10.1016\/j.bbcan.2026.189652_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102786","article-title":"Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses","volume":"56","author":"Raimondi","year":"2020","journal-title":"EBioMedicine"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189652_bb0155","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.7150\/ijbs.96317","article-title":"Leveraging patient-derived organoids for personalized liver cancer treatment","volume":"20","author":"Rao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189652_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101408","article-title":"Fine-needle aspiration-based patient-derived cancer organoids","volume":"23","author":"Vilgelm","year":"2020","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189652_bb0165","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-023-01433-5","article-title":"The functional and clinical roles of liquid biopsy in patient-derived models","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0180","doi-asserted-by":"crossref","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","article-title":"A brief history of organoids","volume":"319","author":"Corr\u00f2","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189652_bb0185","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/pmic.200900758","article-title":"Matrigel: a complex protein mixture required for optimal growth of cell culture","volume":"10","author":"Hughes","year":"2010","journal-title":"Proteomics"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189652_bb0190","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2353\/ajpath.2008.071215","article-title":"To matrigel or not to matrigel","volume":"172","author":"Polykandriotis","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2009.05.005","article-title":"The elastic modulus of Matrigel as determined by atomic force microscopy","volume":"167","author":"Soofi","year":"2009","journal-title":"J. Struct. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189652_bb0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","article-title":"Synthetic alternatives to Matrigel","volume":"5","author":"Aisenbrey","year":"2020","journal-title":"Nat. Rev. Mater."},{"issue":"17","key":"10.1016\/j.bbcan.2026.189652_bb0205","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1039\/C3CS60040H","article-title":"Designing degradable hydrogels for orthogonal control of cell microenvironments","volume":"42","author":"Kharkar","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189652_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41578-019-0129-9","article-title":"Engineered materials for organoid systems","volume":"4","author":"Kratochvil","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bbcan.2026.189652_bb0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-59745-443-8_8","article-title":"Generation of multicellular tumor spheroids by the hanging-drop method","volume":"140","author":"Timmins","year":"2007","journal-title":"Methods Mol. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189652_bb0220","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","article-title":"Tumor organoids: opportunities and challenges to guide precision medicine","volume":"39","author":"Veninga","year":"2021","journal-title":"Cancer Cell"},{"issue":"21","key":"10.1016\/j.bbcan.2026.189652_bb0225","doi-asserted-by":"crossref","first-page":"11448","DOI":"10.1128\/JVI.00678-11","article-title":"Adaptive and innate transforming growth factor beta signaling impact herpes simplex virus 1 latency and reactivation","volume":"85","author":"Allen","year":"2011","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189652_bb0230","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1349-7006.2005.00103.x","article-title":"The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta","volume":"96","author":"Tojo","year":"2005","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189652_bb0235","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41596-020-00433-w","article-title":"Generation and long-term culture of advanced cerebral organoids for studying later stages of neural development","volume":"16","author":"Giandomenico","year":"2021","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189652_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1499","article-title":"Organoid assessment technologies","volume":"13","author":"Gu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189652_bb0245","first-page":"525","article-title":"AI-enabled organoids: construction, analysis, and application","volume":"31","author":"Bai","year":"2024","journal-title":"Bioact. Mater."},{"issue":"18","key":"10.1016\/j.bbcan.2026.189652_bb0250","doi-asserted-by":"crossref","DOI":"10.1242\/dev.199611","article-title":"MOrgAna: accessible quantitative analysis of organoids with machine learning","volume":"148","author":"Gritti","year":"2021","journal-title":"Development (Cambridge, England)"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189652_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008630","article-title":"Rapid 3D phenotypic analysis of neurons and organoids using data-driven cell segmentation-free machine learning","volume":"17","author":"Mergenthaler","year":"2021","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0260","doi-asserted-by":"crossref","first-page":"21487","DOI":"10.1038\/s41598-020-78130-7","article-title":"Multiscale 3D phenotyping of human cerebral organoids","volume":"10","author":"Albanese","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0265","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1038\/s41467-023-37477-x","article-title":"Explainable multi-task learning for multi-modality biological data analysis","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0270","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1038\/s41467-022-33045-x","article-title":"devCellPy is a machine learning-enabled pipeline for automated annotation of complex multilayered single-cell transcriptomic data","volume":"13","author":"Galdos","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189652_bb0275","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2026.189652_bb0280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189652_bb0285","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41596-020-00474-1","article-title":"Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids","volume":"16","author":"Dekkers","year":"2021","journal-title":"Nat. Protoc."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189652_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/mi16101140","article-title":"Bioengineering 3D pancreatic cancer models with fibrotic stroma for in vitro cancer modeling","volume":"16","author":"Lan","year":"2025","journal-title":"Micromachines"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189652_bb0295","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","article-title":"Modeling patient-derived glioblastoma with cerebral organoids","volume":"26","author":"Linkous","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189652_bb0300","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/2159-8290.CD-22-0199","article-title":"Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies","volume":"13","author":"Khan","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0305","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12985-024-02502-y","article-title":"Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel","volume":"21","author":"Lin","year":"2024","journal-title":"Virol. J."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189652_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/v16111764","article-title":"Differential replication and oncolytic effects of zika virus in aggressive CNS tumor cells: insights from organoid and tumoroid models","volume":"16","author":"Ferreira","year":"2024","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcmgh.2018.05.004","article-title":"A high-throughput organoid microinjection platform to study gastrointestinal microbiota and luminal physiology","volume":"6","author":"Williamson","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189652_bb0320","article-title":"Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma organoids","volume":"33","author":"Huberts","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.bbcan.2026.189652_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105219","article-title":"Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures","volume":"105","author":"Sch\u00e4fer","year":"2024","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0330","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cei\/uxae004","article-title":"Revolutionizing immune research with organoid-based co-culture and chip systems","volume":"218","author":"Papp","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-024-03272-x","article-title":"Application status and optimization suggestions of tumor organoids and CAR-T cell co-culture models","volume":"24","author":"Ning","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189652_bb0340","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"issue":"100","key":"10.1016\/j.bbcan.2026.189652_bb0345","doi-asserted-by":"crossref","first-page":"37439","DOI":"10.18632\/oncotarget.26473","article-title":"Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer","volume":"9","author":"Chakrabarti","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189652_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104614","article-title":"Patient-derived melanoma organoid models facilitate the assessment of immunotherapies","volume":"92","author":"Ou","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189652_bb0355","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","article-title":"Patient-derived micro-organospheres enable clinical precision oncology","volume":"29","author":"Ding","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","article-title":"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189652_bb0365","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-20-0455","article-title":"Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189652_bb0370","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1039\/C8LC00596F","article-title":"Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids","volume":"18","author":"Shirure","year":"2018","journal-title":"Lab Chip"},{"issue":"39","key":"10.1016\/j.bbcan.2026.189652_bb0375","doi-asserted-by":"crossref","first-page":"25840","DOI":"10.1021\/acsami.6b08746","article-title":"Design and construction of a multi-organ microfluidic chip mimicking the in vivo microenvironment of lung cancer metastasis","volume":"8","author":"Xu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189652_bb0380","article-title":"Treatment response to oncolytic virus in patient-derived breast cancer and hypopharyngeal cancer organoids: evaluation via a microfluidics organ-on-a-chip system","volume":"12","author":"Sun","year":"2025","journal-title":"Bioengineering (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0385","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/abec2c","article-title":"Engineering bioinks for 3D bioprinting","volume":"13","author":"Decante","year":"2021","journal-title":"Biofabrication"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0390","article-title":"Immersion bioprinting of hyaluronan and collagen bioink-supported 3D patient-derived brain tumor organoids","volume":"18","author":"Clark","year":"2022","journal-title":"Biomed. Mater. (Bristol, England)"},{"issue":"26","key":"10.1016\/j.bbcan.2026.189652_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300905","article-title":"Embedded bioprinting of breast tumor cells and organoids using low-concentration collagen-based bioinks","volume":"12","author":"Shi","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189652_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17223705","article-title":"Colorectal cancer hepatic metastasis modeling by advanced 3D bioprinting allows demonstration of oncolytic viral chemotherapeutic delivery","volume":"17","author":"McGuckin","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189652_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119744","article-title":"Could 3D models of cancer enhance drug screening?","volume":"232","author":"Brancato","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0410","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41598-021-81129-3","article-title":"Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening","volume":"11","author":"Boussaad","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0415","doi-asserted-by":"crossref","first-page":"11071","DOI":"10.1038\/s41598-020-67960-0","article-title":"Automated spheroid generation, drug application and efficacy screening using a deep learning classification: a feasibility study","volume":"10","author":"Benning","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189652_bb0420","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tips.2022.03.014","article-title":"3D cell cultures toward quantitative high-throughput drug screening","volume":"43","author":"Wang","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189652_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100161","article-title":"An automated organoid platform with inter-organoid homogeneity and inter-patient heterogeneity","volume":"1","author":"Jiang","year":"2020","journal-title":"Cell Reports Med."},{"key":"10.1016\/j.bbcan.2026.189652_bb0430","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77007","article-title":"Robotic search for optimal cell culture in regenerative medicine","volume":"11","author":"Kanda","year":"2022","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0435","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1038\/s41467-020-19058-4","article-title":"Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids","volume":"11","author":"Schuster","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189652_bb0440","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0445","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccell.2022.02.001","article-title":"Hepatobiliary tumor organoids for personalized medicine: a multicenter view on establishment, limitations, and future directions","volume":"40","author":"van Tienderen","year":"2022","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189652_bb0450","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.celrep.2019.03.088","article-title":"Establishment of patient-derived organoids and drug screening for biliary tract carcinoma","volume":"27","author":"Saito","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0455","article-title":"Organoid research: advanced models, precision medicine, and translational medicine","volume":"1","author":"Bai","year":"2025","journal-title":"OR"},{"issue":"7705","key":"10.1016\/j.bbcan.2026.189652_bb0460","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-018-0089-z","article-title":"Bioengineering strategies to accelerate stem cell therapeutics","volume":"557","author":"Madl","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0465","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41563-021-01085-1","article-title":"A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids","volume":"21","author":"Below","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bbcan.2026.189652_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121473","article-title":"Hydrogels derived from decellularized liver tissue support the growth and differentiation of cholangiocyte organoids","volume":"284","author":"Willemse","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189652_bb0475","article-title":"Molecular and biomechanical clues from cardiac tissue decellularized extracellular matrix drive stromal cell plasticity","volume":"8(520","author":"Liguori","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0480","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0963180123000300","article-title":"When is something an alternative? A general account applied to animal-free alternatives to animal research","volume":"33","author":"Kramer","year":"2024","journal-title":"Cambridge Quart. Healthcare Ethics CQ Int. J. Healthcare Ethics Committees"},{"issue":"6322","key":"10.1016\/j.bbcan.2026.189652_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9414","article-title":"Human tissues in a dish: the research and ethical implications of organoid technology","volume":"355","author":"Bredenoord","year":"2017","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189652_bb0490","doi-asserted-by":"crossref","first-page":"938","DOI":"10.15252\/embr.201642613","article-title":"Organoid biobanking: identifying the ethics: organoids revive old and raise new ethical challenges for basic research and therapeutic use","volume":"17","author":"Boers","year":"2016","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0495","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.31037","article-title":"Large-scale production of LGR5-positive bipotential human liver stem cells","volume":"72","author":"Schneeberger","year":"2020","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0500","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41577-023-00896-4","article-title":"Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies","volume":"24","author":"Zhou","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"6576","key":"10.1016\/j.bbcan.2026.189652_bb0505","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw9021","article-title":"Tissue geometry drives deterministic organoid patterning","volume":"375","author":"Gjorevski","year":"2022","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189652_bb0510","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-022-01558-x","article-title":"In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice","volume":"41","author":"Bouffi","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbcan.2026.189652_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102151","article-title":"Oncolytic vaccinia virus armed with 4-1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1\/PD-L1 blockade in a pancreatic cancer model","volume":"50","author":"Ju","year":"2024","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189652_bb0520","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/mthe.2002.0547","article-title":"The complement response against an oncolytic virus is species-specific in its activation pathways","volume":"5","author":"Wakimoto","year":"2002","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189652_bb0525","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00109-020-01990-z","article-title":"Cancer research using organoid technology","volume":"99","author":"Kretzschmar","year":"2021","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"22","key":"10.1016\/j.bbcan.2026.189652_bb0530","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170500","article-title":"Recent advances in lung organoid development and applications in disease modeling","volume":"133","author":"Vazquez-Armendariz","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189652_bb0535","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","article-title":"Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses","volume":"13","author":"Farin","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0540","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0545","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1038\/s41467-024-51487-3","article-title":"Generation of human iPSC-derived 3D bile duct within liver organoid by incorporating human iPSC-derived blood vessel","volume":"15","author":"Carolina","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0550","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stem.2023.11.011","article-title":"A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS","volume":"31","author":"Duan","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189652_bb0555","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/gutjnl-2017-314549","article-title":"Human gastric cancer modelling using organoids","volume":"68","author":"Seidlitz","year":"2019","journal-title":"Gut"},{"issue":"52","key":"10.1016\/j.bbcan.2026.189652_bb0560","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189652_bb0565","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189652_bb0570","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13287-022-02902-3","article-title":"Assay establishment and validation of a high-throughput organoid-based drug screening platform","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:05:41Z","timestamp":1785960341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26001241"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189652","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoid-based platforms for oncolytic virus discovery and optimization: Bridging in vitro innovation and clinical translation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189652"}}